Beta-Blocker Influences on Inflammatory and Neural Responses to Stress — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress — Stella

Home/Cardiovascular Disease/

View on ClinicalTrials.gov

Recruiting

Back to Cardiovascular Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Social Neuroscience and Health Laboratory, Chapel Hill, North Carolina

Key details

Phase

Post-approval study

Sponsor

University of North Carolina, Chapel Hill

Collaborators

National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles

Enrollment target

~120 participants

Started

May 2024

Primary completion

May 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

Age range

18 Years – 30 Years

Last updated October 2025